Dolutegravir (DTG) use during pregnancy and birth outcomes: data from the Antiretroviral Pregnancy Registry (APR)

被引：0

作者：

Vannappagari, V. ^{[1
,2
]}

Albano, J. ^{[3
]}

Ragone, L. ^{[1
]}

Cook, T. ^{[3
]}

Scheuerle, A. ^{[4
]}

Short, W. ^{[5
]}

Thorne, C. ^{[6
]}

Beckerman, K. ^{[7
]}

Tilson, H. ^{[2
]}

Chakhtoura, N. ^{[8
]}

Watts, D. H. ^{[9
]}

Mofenson, L. ^{[10
]}

机构：

[1] ViiV Healthcare Epidemiol & Real World Evidence, Res Triangle Pk, NC USA

[2] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA

[3] Syneos Hlth, Wilmington, NC USA

[4] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[5] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[6] UCL, Great Ormond St Inst Child Hlth, London, England

[7] BronxCare Hlth Syst, Carl Icahn Sch Med Mt Sinai, Bronx, NY USA

[8] Eunice Kennedy Shriver NICHD, NIH, Bethesda, MD USA

[9] Global AIDS Coordinator & Hlth Diplomacy, Washington, DC USA

[10] Elizabeth Glaser Pediat AIDS Fdn, Silver Spring, MD USA

来源：

HIV MEDICINE | 2019年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

PS1/2

引用

页码：3 / 4

页数：2

共 50 条

[31] Supplement use by women during pregnancy: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics
Marlene P. Freeman
Alexandra Z. Sosinsky
Danna Moustafa
Adele C. Viguera
Lee S. Cohen
Archives of Women's Mental Health, 2016, 19 : 437 - 441
[32] Supplement use by women during pregnancy: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics
Freeman, Marlene P.
Sosinsky, Alexandra Z.
Moustafa, Danna
Viguera, Adele C.
Cohen, Lee S.
ARCHIVES OF WOMENS MENTAL HEALTH, 2016, 19 (03) : 437 - 441
[33] Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study
Mendes Pereira, Gerson Fernando
Kim, Ahra
Jalil, Emilia M.
Fonseca, Fernanda Fernandes
Shepherd, Bryan E.
Veloso, Valdilea G.
Rick, Fernanda
Ribeiro, Rachel
Pimenta, Maria Cristina
Beber, Andrea
Correa, Renato Girade
Lima, Renato
Maruri, Fernanda
McGowan, Catherine C.
Benzaken, Adele Schwartz
Grinsztejn, Beatriz
Castilho, Jessica L.
LANCET HIV, 2021, 8 (01): : e33 - e41
[34] Use of medication for gastroesophageal reflux during pregnancy and adverse birth outcomes
van Gelder, Marleen
Van Rijt-Weetink, Yrea R. J.
Boleij, Annemarie
van Drongelen, Joris
Smits, Luc
Roeleveld, Nel
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 509 - 510
[35] Adverse birth outcomes associated with use of nicotine products during pregnancy
Cui, Yiwen
Visser, Anna
Tsaih, Shirng-Wern
Palatnik, Anna
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (01) : S148 - S148
[36] Antiretroviral use during pregnancy for treatment or prophylaxis
Sturt, Amy S.
Read, Jennifer S.
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (12) : 1875 - 1885
[37] Use of medication for gastroesophageal reflux during pregnancy and adverse birth outcomes
van Gelder, Marleen M. H. J.
van Rijt-Weetink, Yrea R. J.
Boleij, Annemarie
van Drongelen, Joris
Smits, Luc J. M.
Roeleveld, Nel
NEUROTOXICOLOGY AND TERATOLOGY, 2023, 98
[38] Pregnancy, birth, and infant health outcomes from the national smallpox vaccine in pregnancy registry, 2003-2006
Ryan, Margaret A. K.
Seward, Jane F.
CLINICAL INFECTIOUS DISEASES, 2008, 46 : S221 - S226
[39] Antiepileptic drug use during pregnancy and pregnancy outcomes
Artama, M.
Malm, H.
Ritvanen, A.
Gissier, M.
Paldan, M.
Sevon, T.
Tyrkko, K.
Merilainen, J.
Klaukka, T.
Palva, E.
Nylander, O.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S162 - S163
[40] Use of rivaroxaban during pregnancy and description of pregnancy outcomes
Schink, Tania
Wentzell, Nadine
Voss, Annemarie
Kollhorst, Bianca
Haug, Ulrike
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 250 - 251

← 1 2 3 4 5 →